TGFB1 and atrial fibrillation: We showed that AF susceptibility induced by burst-pacing in cardiac-specific TGF-β–transgenic mice was significantly reduced by the intravenous administration of antagomir-181b, which decreased both subendocardial and interstitial fibrosis in atria; these reductions may contribute to its antiarrhythmic effect.